Concepts (83)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ophthalmology | 2 | 2021 | 550 | 0.870 |
Why?
|
Tonometry, Ocular | 1 | 2018 | 235 | 0.570 |
Why?
|
Ocular Hypertension | 2 | 2018 | 209 | 0.560 |
Why?
|
Glaucoma | 4 | 2021 | 1185 | 0.510 |
Why?
|
Telemedicine | 2 | 2021 | 3041 | 0.280 |
Why?
|
Intraocular Pressure | 4 | 2021 | 1293 | 0.270 |
Why?
|
Retinal Photoreceptor Cell Outer Segment | 1 | 2021 | 13 | 0.200 |
Why?
|
Retinoscopy | 1 | 2021 | 26 | 0.190 |
Why?
|
Electroretinography | 2 | 2021 | 524 | 0.190 |
Why?
|
Geographic Atrophy | 1 | 2021 | 91 | 0.180 |
Why?
|
Eyeglasses | 1 | 2021 | 137 | 0.170 |
Why?
|
Refractive Errors | 1 | 2021 | 147 | 0.170 |
Why?
|
Medicare Part B | 1 | 2020 | 117 | 0.160 |
Why?
|
Prescriptions | 1 | 2021 | 386 | 0.160 |
Why?
|
Trabeculectomy | 1 | 2020 | 174 | 0.160 |
Why?
|
Descemet Stripping Endothelial Keratoplasty | 1 | 2020 | 112 | 0.150 |
Why?
|
Endothelium, Corneal | 1 | 2020 | 215 | 0.150 |
Why?
|
Fluorescein Angiography | 1 | 2021 | 1059 | 0.130 |
Why?
|
Eye Diseases | 1 | 2021 | 655 | 0.130 |
Why?
|
Fluocinolone Acetonide | 1 | 2014 | 38 | 0.120 |
Why?
|
Chorioretinitis | 1 | 2014 | 43 | 0.120 |
Why?
|
Corneal Diseases | 1 | 2020 | 541 | 0.120 |
Why?
|
Glaucoma, Open-Angle | 1 | 2021 | 738 | 0.110 |
Why?
|
Reoperation | 2 | 2020 | 4302 | 0.110 |
Why?
|
Tomography, Optical Coherence | 2 | 2021 | 2915 | 0.090 |
Why?
|
Visual Acuity | 3 | 2021 | 2671 | 0.060 |
Why?
|
Glucocorticoids | 1 | 2014 | 2163 | 0.060 |
Why?
|
Anti-Inflammatory Agents | 1 | 2014 | 1809 | 0.060 |
Why?
|
Pandemics | 2 | 2021 | 8635 | 0.060 |
Why?
|
Photochemotherapy | 1 | 2011 | 823 | 0.060 |
Why?
|
Reproducibility of Results | 2 | 2021 | 20092 | 0.060 |
Why?
|
Medicare | 1 | 2020 | 6758 | 0.050 |
Why?
|
Retrospective Studies | 5 | 2021 | 80575 | 0.050 |
Why?
|
Choroid Hemorrhage | 1 | 2020 | 6 | 0.050 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 26108 | 0.040 |
Why?
|
Refraction, Ocular | 1 | 2021 | 183 | 0.040 |
Why?
|
Fundus Oculi | 1 | 2021 | 556 | 0.040 |
Why?
|
Corneal Edema | 1 | 2020 | 47 | 0.040 |
Why?
|
Macaca fascicularis | 1 | 2021 | 903 | 0.040 |
Why?
|
Infant | 1 | 2021 | 36202 | 0.040 |
Why?
|
Diagnostic Techniques, Ophthalmological | 1 | 2021 | 251 | 0.040 |
Why?
|
Retinal Pigment Epithelium | 1 | 2021 | 303 | 0.040 |
Why?
|
Fuchs' Endothelial Dystrophy | 1 | 2020 | 103 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2020 | 15647 | 0.040 |
Why?
|
Endophthalmitis | 1 | 2020 | 260 | 0.040 |
Why?
|
Siblings | 1 | 2021 | 825 | 0.030 |
Why?
|
Humans | 11 | 2021 | 761326 | 0.030 |
Why?
|
Family Health | 1 | 2021 | 1257 | 0.030 |
Why?
|
Retinal Detachment | 1 | 2020 | 428 | 0.030 |
Why?
|
Aged | 4 | 2021 | 169179 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2021 | 2075 | 0.030 |
Why?
|
Probability | 1 | 2020 | 2478 | 0.030 |
Why?
|
Drug Implants | 1 | 2014 | 230 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2021 | 39108 | 0.030 |
Why?
|
Intravitreal Injections | 1 | 2014 | 385 | 0.030 |
Why?
|
Male | 5 | 2021 | 360621 | 0.030 |
Why?
|
Female | 5 | 2021 | 392485 | 0.020 |
Why?
|
Delayed-Action Preparations | 1 | 2014 | 962 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 6473 | 0.020 |
Why?
|
Graft Survival | 1 | 2020 | 3818 | 0.020 |
Why?
|
Middle Aged | 2 | 2021 | 220774 | 0.020 |
Why?
|
Cataract | 1 | 2014 | 832 | 0.020 |
Why?
|
Visual Fields | 1 | 2014 | 1062 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2021 | 3204 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2021 | 12329 | 0.020 |
Why?
|
Photosensitizing Agents | 1 | 2011 | 623 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2020 | 12450 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10498 | 0.020 |
Why?
|
Adjuvants, Immunologic | 1 | 2011 | 1036 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2020 | 58946 | 0.020 |
Why?
|
Mass Screening | 1 | 2021 | 5428 | 0.020 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2011 | 1783 | 0.010 |
Why?
|
United States | 2 | 2020 | 72317 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2021 | 18234 | 0.010 |
Why?
|
Neoplasms | 1 | 2011 | 22158 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7872 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 54405 | 0.010 |
Why?
|
Young Adult | 1 | 2021 | 59196 | 0.010 |
Why?
|
Adult | 2 | 2021 | 221122 | 0.010 |
Why?
|
Risk Factors | 1 | 2020 | 74152 | 0.010 |
Why?
|
Adolescent | 1 | 2021 | 88305 | 0.010 |
Why?
|
Child | 1 | 2021 | 80156 | 0.010 |
Why?
|
Animals | 1 | 2021 | 168388 | 0.010 |
Why?
|
Concepts
(83)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(12)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_